Wikidata

(Q63338535)

English

Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

clinical trial

In more languages

Statements

title
Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Doses of Oral Dalfampridine Extended Release Tablets (5 mg and 10 mg Twice Daily) in Patients With Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
start time
March 2011
0 references
end time
April 2012
0 references
number of participants
430
0 references
minimum age
18 year
0 references
maximum age
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63338535&oldid=1857168434"